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Abstract
Background: Periodontal disease is associated with increased mortality in the general population, however its
prognostic significance in chronic kidney disease (CKD) is not known. We evaluated the joint effect of periodontal
disease and CKD on all-cause and cardiovascular mortality.
Methods: Prospective observational study of 10,755 adult participants in the National Health and Nutrition
Examination Survey, 1988–1994 (NHANES III). CKD was defined as estimated glomerular filtration rate < 60 ml/minute/
1.73 m2 or albumin-to-creatinine ratio ≥ 30 mg/g. Periodontal disease was defined as moderate (> 4 mm attachment
loss in ≥ 2 mesial sites or 5 mm pocket depth in ≥ 2 mesial sites), or severe (> 6 mm attachment loss in≥ 2 mesial
sites and > 5 mm pocket depth in≥ 1 mesial site). All-cause and cardiovascular mortality were evaluated using Cox
proportional hazards models.
Results: There were 1,813 deaths over a median follow-up of 14 years. In multivariate analyses, as compared to
participants with neither periodontal disease nor CKD, those with periodontal disease only or CKD only had increased
all-cause mortality (HR 1.39; 95 % CI, 1.06 - 1.81 and 1.55; 1.30 - 1.84, respectively). The presence of both periodontal
disease and CKD was associated with HR (95 % CI) 2.07 (1.65 - 2.59) for all-cause mortality, and 2.11 (1.52 - 2.94) for
cardiovascular mortality. We found no evidence of multiplicativity or additivity between periodontal disease and
CKD. In stratified analyses limited to individuals with CKD, periodontal disease (vs. not) was associated with
adjusted HR (95 % CI) 1.35 (1.04 - 1.76) for all-cause, and 1.36 (0.95 - 1.95) for cardiovascular mortality.
Conclusions: These findings confirm the well-established association between periodontal disease and increased
mortality in the general population, and provide new evidence of this association among individuals with CKD.
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Background
Chronic kidney disease (CKD) stages 1–5 affects ap-
proximately 26 million individuals in the United States
(U.S.) and the size of this population is expected to grow
[1]. It is well established that individuals with CKD are
at increased risk for cardiovascular morbidity and mor-
tality compared to the general population [2, 3]. How-
ever, traditional risk factors do not fully account for the
heightened cardiovascular risk in the CKD population
[4]. Therefore, investigation of novel and potentially
modifiable risk factors is warranted.
Periodontal disease is a common, chronic inflamma-
tory condition of the tissues surrounding the teeth
caused by accumulation of bacteria which can lead to
tooth loss [5]. In the general population, periodontal dis-
ease has been associated with all-cause mortality and
cardiovascular mortality [6–11],which is thought to be
mediated by endothelial dysfunction caused by cytokines
and inflammatory factors released in response to chronic
bacterial infection in the oral cavity, ultimately leading to
atherosclerosis [12]. Less is known about the association
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of periodontal disease with CKD. Several cross-sectional
studies have reported a potential link between periodontal
disease and CKD [13–15], with a potential bidirectional
relationship mediated by hypertension and diabetes [16].
Similar to cardiovascular disease (CVD), chronic inflam-
mation is considered a risk factor for CKD; therefore, it
has been postulated that the increased risk for CKD in in-
dividuals with periodontal disease might be related to in-
flammatory cytokines (e.g., interleukin 6, tumor necrosis
factor, thromboxane B2) which may lead to atherosclerotic
changes and thrombus formation in the renal vasculature
[13, 17].
We conducted a study to assess the joint effect of peri-
odontal disease and CKD on mortality among National
Health and Nutrition Examination Survey, 1988–1994
(NHANES III) participants. We hypothesized that the
presence of both periodontal disease and CKD would be




NHANES III was a cross-sectional, stratified, clustered,
multistage probability sample survey of the civilian, nonin-
stitutionalized U.S. population, conducted by the National
Center for Health Statistics (NCHS) between 1988 and
1994 [18, 19]. The survey protocol was approved by the
NCHS institutional review board. All participants pro-
vided informed consent. Participants underwent a home
interview followed by an extensive physical examination
(including an assessment of periodontal disease as de-
scribed below) and blood and urine sampling at a mobile
examination center (MEC). Self-reported information on
sociodemographic characteristics and presence of medical
conditions was collected during the home interview.
Blood pressure (BP), blood and urine samples were ob-
tained during the physical examination.
Exposure ascertainment
Periodontal measures
Periodontal measures were done on randomly assigned
half-mouths, one upper quadrant and one lower quad-
rant selected at the beginning of the examination [19].
The buccal and mesial-buccal aspects of each tooth were
scored separately for each periodontal measure: gingival
bleeding, calculus, gingival recession, and pocket depth.
Loss of attachment was derived from two measurements
made at each site: (1) the distance from the free gingival
margin to the cemento-enamel junction, and (2) the dis-
tance from the free gingival margin to the bottom of the
sulcus (pocket depth). When the gingival margin had re-
ceded and the cemento-enamel junction was exposed,
the first number was scored as a negative value and was
an indication of gingival recession. The loss (level) of
attachment variables was calculated by subtracting the
recorded distance of the free gingival margin to cemento-
enamel junction (1) from the recorded distance of the free
gingival margin to the base of the sulcus (2). Periodontal
disease was defined based on the Centers for Disease Con-
trol and Prevention (CDC) criteria [20, 21] as follows:
moderate periodontal disease as at least 2 mesial sites
with > 4 mm attachment loss or at least 2 mesial sites with
5 mm pocket depth (not on the same tooth), and severe
periodontal disease as at least 2 mesial sites with > 6 mm
attachment loss and one or more mesial sites with > 5 mm
pocket depth. For the purposes of this study, individuals
with either moderate or severe disease were classified as
having periodontal disease.
Kidney function measures
CKD was defined by either an estimated glomerular
filtration rate (eGFR) < 60 ml/min/1.73 m2, using the
CKD epidemiology collaboration (CKD-EPI) equation
for creatinine [22] or the presence of urine albumin-to-
creatinine ratio (ACR) ≥ 30 mg/g. We used the formula
for correction of serum creatinine recommended in the
NHANES III Data File Documentation [23].
Outcome ascertainment
Vital status was determined using the NHANES III
Linked Mortality Public-use File, which provides vital
status follow-up data in person-months from the date of
the NHANES III survey participation through the date
of death or 12/31/2006. Mortality was ascertained by the
NCHS through a probabilistic match between NHANES
III participants and National Death Index death certifi-
cate records. Participants who were not matched with
any death records were considered to be alive through
the follow-up period [24]. For this study, cardiovascular
mortality was defined as death due to diseases of the
heart, essential hypertension and hypertensive kidney
disease, cerebrovascular disease, atherosclerosis, and
other diseases/disorders of the circulatory system
(codes I00-I99).
Covariates definition
Race/ethnicity was categorized as non-Hispanic White,
non-Hispanic Black, Mexican American, or other. Income
was classified as annual family income < 20,000 or
≥ 20,000 U.S. dollars. Educational attainment was catego-
rized as less than high school or ≥ high school. Partici-
pants were considered to have health insurance if they
self-reported coverage by Medicare, Medicaid, CHAM-
PUS/Veterans Affairs, or any other health insurance plan
over the preceding month.
Dental care use was defined as “recommended” if the
last dental visit was < 1 year prior and for a routine rea-
son, or “less than recommended” if the last dental visit
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was > 1 year ago, for a problem, or for another reason
[15]. Participants were classified as current, past or
never smoker based on responses to the questions “Have
you smoked at least 100 cigarettes during your entire
life?” and “Do you smoke cigarettes now?” Participants
had three BP measurements at the MEC in the sitting
position, after 5 minutes of rest, using a standardized
protocol. [18] The averages of all systolic BP available
readings are reported here. Hypertension was defined as
BP > 140/> 90 mmHg or the use of antihypertensive
medications. Diabetes was defined as a history of dia-
betes, use of insulin or other medication to treat dia-
betes, a fasting blood glucose ≥126 mg/dL, or a random
blood glucose ≥ 200 mg/dL. Participants were considered
to have CVD if they self-reported history of myocardial
infarction, stroke, or congestive heart failure. Family his-
tory of CVD was defined as having a first degree relative
with history of myocardial infarction at age < 50 yrs.
Body mass index (BMI) was calculated as weight in kilo-
grams divided by height in meters squared. Hemoglobin
A1c (HbA1c) was measured using the Diamat Analyzer
System. Serum C-reactive protein was quantified using
latex-enhanced nephelometry. White blood cell count
determination was made using a Coulter Counter. Fi-
brinogen was measured in citrated plasma using an au-
tomated coagulation analyzer [25].
Statistical methods
NCHS recommendations were followed to account for
stratification and clustering of the survey design, as well
as oversampling of ethnic minorities and elderly persons
[23]. Continuous variables were expressed as means
(standard error) or medians (interquartile range) if not
normally distributed; and categorical variables as weighted
percentage. Chi-squared and Student’s t tests were used to
compare categorical and continuous variables, respect-
ively. Cox proportional hazards models were used to de-
termine the joint effect of periodontal disease and CKD
on mortality adjusting for important covariates (age, gen-
der, race/ethnicity, education, annual income, diabetes,
hypertension, smoking, CVD, BMI, family history of pre-
mature CVD, HbA1c, total cholesterol and systolic BP)
which were chosen based on prior literature [10, 13, 14].
We did not include C-reactive protein, fibrinogen or white
blood cell count in the regression models because markers
of inflammation are thought to be in the causal pathway
of the association between periodontal disease and mortal-
ity [10, 17]. We conducted formal tests for multiplicativity
and additivity between periodontal disease and CKD on
all-cause and cardiovascular mortality. Additional multivar-
iable analyses were conducted to evaluate the joint effect of
periodontal disease and albuminuria (ACR ≥ 30 mg/g), and
of periodontal disease and low eGFR (< 60 mL/min/
1.73 m2) on outcomes; these models included the variables
listed above in addition to eGFR and natural log of urine
ACR, respectively. Stratified analyses by CKD status were
also conducted. All tests were two-sided, and p < 0.05 was
considered significant for hypothesis testing. The
proportional hazards assumption of the Cox models
was examined using Schoenfeld residuals, which
showed no significant departure from proportionality
over time (p >0.05) [26]. We used SAS 9.3 (Cary, NC).
Results
Of the 13,358 NHANES III adult (age ≥ 18 years) men and
non-pregnant women who were examined and completed
a periodontal disease assessment, we excluded participants
due to missing data on serum creatinine (747), urine ACR
(187), income (180), health insurance (561), hypertension
(97), CVD (150), family history of CVD (200), HbA1c (58)
or other covariates (423). Therefore, our final analytic
sample included 10,755 individuals of which 1,335 met
criteria for CKD. Compared with participants who were
included in analyses, those who were excluded due to
missing data were more likely to be older (mean age
49.3 vs. 41.5 years, p < 0.001); female (54.6 vs. 50.0 %,
p < 0.001); and to have less than high school education
(74.9 vs. 63.5 %, p < 0.001). There was no difference in
racial/ethnic background distribution.
The overall prevalence of CKD was 12.4 % and the
prevalence of periodontal disease was 7.6 %. Periodontal
disease was significantly more common in participants
who met criteria for CKD as compared to those who did
not (9.2 vs. 4.8 %, p <0.001). The median follow-up time
was 14 years.
Among individuals with and without CKD, those who
had periodontal disease were more likely to be older,
have annual family income < $20,000, and have less than
high school education (Table 1). Participants with peri-
odontal disease were also more likely to have less dental
care visits, less annual physician visits; and were more
likely to be smokers and have preexisting CVD and dia-
betes. Systolic BP was significantly higher among partici-
pants with periodontal disease compared with those with
no periodontal disease, regardless of CKD status. Health
insurance status was not associated with periodontal dis-
ease in participants with or without CKD. Among partici-
pants without CKD, the levels of HbA1c, total cholesterol,
C-reactive protein, white blood cell count and plasma
fibrinogen were statistically significantly higher in individ-
uals with periodontal disease compared with those with
no periodontal disease; however, given the magnitude of
the absolute difference, the clinical significance is unclear.
These differences in laboratory values were not statistically
significant among participants with CKD (Table 1).
Table 2 summarizes event rates and hazard ratios for
all-cause and cardiovascular mortality, sequentially ad-
justed for the following variables: a) Model 1: age, gender,
Ricardo et al. BMC Nephrology  (2015) 16:97 Page 3 of 7
race/ethnicity, education, annual income; b) Model 2: Var-
iables in Model 1 plus diabetes, hypertension, smoking,
CVD, BMI, family history of premature CVD, HbA1c,
total cholesterol and systolic BP. In fully adjusted models,
as compared to participants with neither periodontal dis-
ease nor CKD, those with periodontal disease only or
CKD only had increased risk of all-cause mortality (HR
1.39; 95 % CI, 1.06-1.81 and 1.55; 1.30-1.84, respectively).
The presence of both periodontal disease and CKD was
associated with HR, 2.07; 95 % CI, 1.65-2.59 for all-cause
mortality and HR, 2.11; 95 % CI, 1.52-2.94 for cardio-
vascular mortality. Similar results were observed when
we examined the joint effect of periodontal disease with
low eGFR, and periodontal disease with albuminuria
(Table 2). We did not find evidence of significant addi-
tivity or multiplicativity between periodontal disease
and CKD on the outcomes of all-cause mortality (p value
0.8 and 0.9, respectively) or cardiovascular mortality
(p value 0.9 for each).
In stratified analyses by CKD status, periodontal
disease was associated with fully adjusted HR (95 % CI)
1.35 (1.04-1.76) for all-cause mortality and 1.36 (0.95-
1.95) for cardiovascular mortality among individuals
with CKD.
Discussion
In a nationally representative sample of the U.S. popula-
tion with 14 years of follow-up, our findings confirm the
well-established association between periodontal disease
and increased mortality in the general population, and
provide new evidence of this association among individ-
uals with CKD.
Over the past two decades, there has been accumulat-
ing evidence suggesting a link between periodontal





Disease N = 193
No Periodontal
Disease N = 1142
P Periodontal
Disease N = 625
No Periodontal
Disease N = 8795
P
Characteristic Weighted Mean (SE) or Weighted %
Age, years 41.5 (0.5) 62.8 (1.6) 51.9 (1.2) <0.001 53.5 (1.0) 39.6 (0.4) <0.001
Female 50.0 42.2 62.1 <0.001 31.9 49.8 <0.001
Race
Non-Hispanic White 75.7 69.5 73.5 0.4 67.2 76.4 0.004
Non-Hispanic Black 10.7 25.1 11.9 <0.001 16.9 10.2 <0.001
Mexican American 5.5 3.9 4.6 0.5 4.2 5.6 0.007
Other 8.2 1.5 10.0 0.001 11.7 7.9 0.1
Annual Income < $20,000 27.9 60.9 35.3 <0.001 39.9 26.3 <0.001
< High School Education 63.5 89.9 70.1 <0.001 77.8 61.8 <0.001
Health Insurance 86.5 88.8 89.7 0.8 85.9 86.2 0.9
Dental care use 71.0 49.5 70.10 <0.001 60.3 71.8 <0.001
Annual Physician visit 77.2 75.7 88.5 0.003 72.1 76.4 0.1
Never Smoked 48.4 25.0 46.5 <0.001 22.3 50.1 <0.001
Hypertension 20.4 44.3 42.2 0.7 28.5 17.7 <0.001
Diabetes 5.8 30.7 20.3 0.03 10.8 3.9 <0.001
Cardiovascular Disease 3.4 16.7 9.8 0.02 10.4 2.3 <0.001
Family history of CHD 9.2 13.2 9.7 0.4 12.2 8.9 0.2
Body Mass Index, Kg/m2 26.4 (0.1) 28.1 (0.7) 27.8 (0.4) 0.7 27.1 (0.2) 26.2 (0.1) <0.001
Systolic BP 120.6 (0.4) 143.0 (1.9) 131.6 (1.0) <0.001 128.8 (1.1) 119.0 (0.3) <0.001
Hemoglobin A1c, % 5.3 (0.02) 6.4 (0.37) 5.9 (0.08) 0.07 5.7 (0.08) 5.2 (0.02) <0.001
Total Cholesterol, mg/dL 200.3 (0.9) 220.3 (5.1) 213.3 (2.0) 0.3 214.9 (2.0) 198.1 (0.9) <0.001
c-Reactive Protein, mg/dL 0.4 (0.01) 0.6 (0.05) 0.6 (0.04) 0.9 0.5 (0.04) 0.3 (0.01) <0.001
White Blood Cell Count/μL 7.2 (0.04) 8.3 (0.34) 7.5 (0.13) 0.05 7.9 (0.16) 7.1 (0.04) <0.001
Plasma Fibrinogen, mg/dL* 298.3 (2.7) 342.0 (8.0) 328.1 (6.5) 0.1 312.9 (6.1) 291.6 (2.7) <0.001
*Plasma Fibrinogen was only measured in participants aged 40 years and older
Abbreviations: BP, blood pressure; CHD, coronary heart disease
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disease and increased cardiovascular risk. In a recently
published study of 1200 Veterans with median follow-up
of 24 years, chronic periodontal disease was associated
with an increased risk for incident coronary heart dis-
ease [9]. A number of other epidemiological studies have
also reported an association between periodontal disease
and cardiovascular events and all-cause mortality in the
general population [6–8, 10, 11]. In contrast, this associ-
ation was not found in the Physicians’ Health and Health
Professionals Study [27, 28]. However, it has been specu-
lated that the negative findings in these two studies may be
due to the fact that periodontal disease was assessed by
self-report rather than by a dental examination. Of note,
most of the studies published to date evaluating the
association between periodontal disease and outcomes
have focused on general populations and therefore have
not included a significant number of individuals with
CKD.
Several cross-sectional studies have reported an associ-
ation between periodontal disease and CKD. Analyses from
the Atherosclerosis Risk in Communities Study and
NHANES reported that periodontal disease was associated
with a two-fold increased risk for prevalent CKD [13–15].
The cross-sectional design of these studies limits our ability
to understand reasons for this association. It is possible that
CKD leads to increased susceptibility to periodontal disease
or that the chronic infectious and inflammatory milieu of
periodontal disease may increase susceptibility to develop
Table 2 Cox proportional hazards models for all-cause and cardiovascular mortality evaluating the joint effect of periodontal disease
and chronic kidney disease
Events, N Mortality Rate (1000 P-Y) Model 1a, HR (95 % CI) Model 2b, HR (95 % CI)
All-cause Mortality
(−) Periodontal Disease, (−) CKD 970 5.44 Reference Reference
(+) Periodontal Disease, (−) CKD 228 21.33 1.67 (1.30,2.14) 1.39 (1.06,1.81)
(−) Periodontal Disease, (+) CKD 476 24.93 1.85 (1.57,2.18) 1.55 (1.30,1.84)
(+) Periodontal disease, (+) CKD 139 65.20 2.69 (2.14,3.40) 2.07 (1.65,2.59)
(−) Periodontal Disease, (−) Low eGFR 1182 5.98 Reference Reference
(+) Periodontal Disease, (−) Low eGFR 293 23.80 1.65 (1.33,2.06) 1.39 (1.09,1.77)
(−) Periodontal Disease, (+) Low eGFR 264 56.78 1.58 (1.30,1.93) 1.39 (1.12,1.71)
(+) Periodontal disease, (+) Low eGFR 74 112.35 2.28 (1.72,3.02) 1.68 (1.20,2.36)
(−) Periodontal Disease, (−) Albuminuria 1140 6.13 Reference Reference
(+) Periodontal Disease, (−) Albuminuria 268 23.29 1.63 (1.30,2.06) 1.40 (1.09,1.81)
(−) Periodontal Disease, (+) Albuminuria 306 19.44 2.12 (1.78,2.52) 1.65 (1.39,1.98)
(+) Periodontal disease, (+) Albuminuria 99 58.86 2.68 (2.06,3.49) 1.90 (1.47,2.46)
Cardiovascular Mortality
(−) Periodontal Disease, (−) CKD 353 1.91 Reference Reference
(+) Periodontal Disease, (−) CKD 84 7.60 1.59 (1.06,2.38) 1.33 (0.88,2.01)
(−) Periodontal Disease, (+) CKD 243 13.68 2.30 (1.89,2.80) 1.74 (1.41,2.15)
(+) Periodontal disease, (+) CKD 72 33.32 3.03 (2.18,4.21) 2.11 (1.52,2.94)
(−) Periodontal Disease, (−) Low eGFR 445 2.23 Reference Reference
(+) Periodontal Disease, (−) Low eGFR 117 9.15 1.59 (1.19,2.12) 1.33 (0.99,1.79)
(−) Periodontal Disease, (+) Low eGFR 151 33.30 1.79 (1.33,2.41) 1.45 (1.05,1.99)
(+) Periodontal disease, (+) Low eGFR 39 55.04 2.21 (1.38,3.56) 1.45 (0.80,2.62)
(−) Periodontal Disease, (−) Albuminuria 450 2.35 Reference Reference
(+) Periodontal Disease, (−) Albuminuria 106 8.59 1.51 (1.05,2.18) 1.38 (0.94,2.03)
(−) Periodontal Disease, (+) Albuminuria 146 10.07 2.56 (2.06,3.19) 1.78 (1.40,2.28)
(+) Periodontal disease, (+) Albuminuria 50 29.67 2.90 (1.91,4.43) 1.75 (1.12,2.73)
aModel1: Adjusted for age (continuous), gender, race/ethnicity (Non-Hispanic White, Non-Hispanic Black, Mexican-American or other), education (< vs. ≥ high
school) and annual income (< vs. ≥ $20,000)
bModel 2: Adjusted for variables in Model 1 plus diabetes, hypertension, smoking (never vs. current/past), cardiovascular disease, BMI (continuous), family history
of premature CVD, HbA1c, total cholesterol and systolic BP. In addition, analyses of periodontal disease and eGFR were adjusted for natural log of urine albumin-
to-creatinine ratio; and analyses of periodontal disease and albuminuria were adjusted for eGFR
Abbreviations: CKD, chronic kidney disease (defined as either low estimated glomerular filtration rate [eGFR < 60 ml/min/1.73 m2] or the presence of albuminuria
[urine albumin-to-creatinine ratio ≥ 30 mg/g])
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CKD. Alternatively, the relationship could be bidirectional
as it has been proposed [16]. Two prior longitudinal studies
have evaluated the association of periodontal disease with
kidney function: a retrospective cohort analysis from 317
elderly men and women from Japan showed that during a
2-year follow-up, periodontal disease was associated with a
greater than 2-fold risk of decreased kidney function; [29]
and a study 529 individuals with type 2 diabetes followed
by 22 years which reported higher incidence of end-stage
renal disease in persons with moderate or severe periodon-
titis compared with those with none or mild periodontitis
[30]. However, the association of periodontal disease and
CKD with mortality has not been previously assessed. We
hypothesized that there would be a significant joint effect
of periodontal disease and CKD on all-cause and cardiovas-
cular mortality, but we found this not to be the case. These
findings might indicate that the mechanisms underlying the
association between periodontal disease and mortality, and
CKD and mortality, may be similar.
This represents the first prospective evaluation of the
association of periodontal disease with mortality in
persons with CKD. In stratified analyses restricted to
participants with CKD, individuals with periodontal dis-
ease had 35 % increased risk for all-cause mortality as
compared to individuals without periodontal disease,
findings that are similar to what has been observed in
studies of non-CKD populations. However, we found no
significant association between periodontal disease and
cardiovascular mortality which might have been due to
lack of statistical power. The association between peri-
odontal disease and mortality among individuals with
CKD is of particular relevance because periodontal
disease represents a potentially modifiable risk factor.
Although there is some evidence that treatment of peri-
odontal disease is associated with a reduction in markers
of inflammation and endothelial function [31], the
impact of intervention on clinical outcomes has not
been studied.
Conclusions
This study provides the first evidence that among indi-
viduals with CKD, periodontal disease increases the risk
for mortality. Further studies are needed to assess
whether treatment of periodontal disease can improve
outcomes for patients with CKD. In the meantime, the
increased prevalence of periodontal disease in CKD and
its association with increased mortality risk suggest that
general population recommendations for regular dental
exams and oral hygiene should be emphasized among
CKD patients.
Strengths and limitations
The strengths of this study are long duration of follow
up and a nationally representative sample. However, our
study has several limitations. First, CKD was defined by
single measurement of eGFR and albuminuria which
could lead to misclassification. Second, periodontal dis-
ease status was only evaluated in one-half of the mouth
which could lead to an underestimation of prevalence.
Moreover, we based our periodontal disease definition
on the criteria proposed by the CDC for use in
population-based surveillance of periodontitis which
might also underestimate the prevalence of periodontal
disease [32]. Nonetheless, we still found a robust associ-
ation with mortality. Third, periodontal disease was
evaluated only once and therefore, we were unable to ac-
count for development of the disease during follow-up,
exacerbations and treatment. However, interval peri-
odontal disease treatment would have biased the results
toward the null hypothesis.
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